Critical Contrast: Synergy CHC (NASDAQ:SNYR) and Unicharm (OTCMKTS:UNICY)
SNYR: 8-K · delisting
Synergy CHC Corp. received a delisting notice from Nasdaq's Listing Qualifications staff on September 11, 2026, and the trading of its common stock (SNYR) will be suspended at the opening of business on September 18, 2026. The delisting determination is based on the company's voluntary Chapter 11 bankruptcy filing on September 4, 2026, along with Nasdaq's concerns about the residual equity interest of existing shareholders and the company's ability to sustain compliance with continued listing requirements. The company does not intend to appeal the staff's determination, and a Form 25-NSE will be filed with the SEC to remove the securities from Nasdaq — leaving shareholders facing suspension of trading and deeply impaired equity in a bankrupt issuer.
SNYR: 8-K · bankruptcy
Synergy CHC Corp. filed a voluntary chapter 11 bankruptcy petition on September 4, 2026 in the United States Bankruptcy Court for the District of Columbia, Case No. 26-465-ELG. The company is now operating as a debtor-in-possession with its assets under Bankruptcy Court jurisdiction and anticipates filing a plan of liquidation or reorganization within 120 days. In connection with the filing, directors Alfred Baumeler, Nitin Kaushal, J. Paul SoRelle and Teresa Thompson all resigned effective September 4, 2026, leaving Jack Ross as the sole remaining board member. Alfred Baumeler had separately resigned as President effective August 31, 2026. The company engaged Lauren P. Berret of Eisner Advisory Group LLC as chief restructuring officer effective August 26, 2026, and retained The VerStandig Law Firm, LLC as bankruptcy counsel. The near-total board exodus plus restructuring leadership suggests a wind-down or deep reorganization is the likely path forward for SNYR.
SNYR: 8-K · debt financing
Synergy CHC Corp. (SNYR) received a Notice of Acceleration on August 25, 2026 from ACP Agency, LLC, agent under its May 30, 2025 Term Loan Credit Agreement, declaring all obligations immediately due and payable. Per the notice, approximately $18.9 million was due and payable as of August 21, 2026, exclusive of additional interest, fees, costs and expenses that continue to accrue, and all lender commitments under the credit agreement have been terminated. The acceleration follows events of default the company disclosed in an 8-K filed August 11, 2026, and ACP acted at the direction of the required lenders, signaling active remedy enforcement and elevated restructuring or enforcement risk for the company.
Synergy CHC Corp. Announces Receipt of Nasdaq Letter
Synergy CHC received a non-compliance notice from Nasdaq because it failed to timely file its Form 10-Q for the quarter ended June 30, 2026. The company has 60 calendar days, until October 19, 2026, to submit a plan to regain compliance, though Nasdaq may grant an extension up to February 10, 2027. Management stated it currently cannot predict when or if the required report will be filed, casting doubt on the firm's ability to maintain its listing.
On August 11, 2026, Synergy CHC Corp. received a notice of default from ACP Agency, LLC, the administrative and collateral agent under its Term Loan Credit Agreement dated May 30, 2025, asserting an Event of Default caused by the company's failure to make the interest payment due August 3, 2026 after the cure period expired on August 6, 2026. ACP stated that the forbearance period under the Forbearance Agreement dated May 28, 2026 terminated on August 6, 2026, and that a forbearance fee of $404,173.06 is now due and payable. Approximately $17.6 million of principal remains outstanding under the Credit Agreement, exclusive of accrued interest, fees and expenses. ACP has reserved its rights to charge post-default interest, accelerate the obligations, and exercise other remedies, leaving Synergy CHC exposed to potential full loan acceleration and heightened refinancing or liquidity risk.
SNYR: 8-K · other
Costco Wholesale Corporation notified Synergy CHC Corp. that it will discontinue carrying the Company's FOCUSfactor products. Costco has been a significant customer for more than 16 years and accounted for approximately 58% of the Company's net revenue during the fiscal year ended December 31, 2025. The Company expects Costco's decision to have a material adverse effect on its business, results of operations, liquidity and financial condition and is evaluating available financing and other strategic alternatives.
SNYR: 8-K · proxy statement
Synergy CHC stockholders approved an amendment to the 2024 Equity Incentive Plan, increasing the share reserve to 150 million shares and allowing the repricing of outstanding awards without further shareholder approval. Investors also authorized the board to implement a reverse stock split at a ratio not to exceed 1-for-200, signaling an effort to boost the stock price to maintain listing compliance. The 2026 annual meeting resulted in the ratification of RBSM LLP as the independent auditor and the election of five directors, including CEO Jack Ross.
Synergy CHC Corp. (SNYR) Shareholder/Analyst Call Prepared Remarks Transcript
Synergy CHC Corp. (SNYR) received a formal notice from Nasdaq on May 15, 2026, stating that its common stock failed to meet the minimum bid price requirement for continued listing. The company’s closing bid price remained below $1.00 for 30 consecutive business days, triggering a violation of Nasdaq Listing Rule 5550(a)(2). The notice does not result in immediate delisting. Instead, Synergy CHC has an initial compliance period of 180 calendar days, ending on November 11, 2026, to regain compliance. To cure the deficiency, the stock must trade at or above $1.00 for at least 10 consecutive business days within this window. If the company fails to regain compliance by the deadline, it may be eligible for an additional 180-day extension, provided it meets other listing standards and potentially effects a reverse stock split. The company stated it will monitor its stock price and consider available options, but offered no assurance of regaining compliance.
SNYR: S-1 · offering registration
Synergy CHC Corp. (SNYR) filed an S-1 registration statement to register up to 101.7 million shares of common stock for resale by Hudson Global Ventures, LLC. These shares consist of 100 million ELOC shares, 1.54 million warrant shares, and 170,000 existing shares, under an Equity Purchase Agreement dated May 8, 2026. The company may sell up to $36 million in ELOC shares to Hudson Global at a price discounted by 5% from the market price. This structure allows for potential dilution of up to 89% of the current outstanding shares if the full commitment is utilized, significantly impacting existing shareholders. For the fiscal year ended December 31, 2025, Synergy reported revenue of $30.4 million, a 12.6% decline from the prior year, and a net loss of $12.3 million. The loss was driven by a $6.7 million bad debt reserve and a $0.9 million inventory write-off, highlighting ongoing financial pressures despite a working capital surplus of $1.8 million.
Synergy CHC Corp. (SNYR) Reports Q1 Loss, Misses Revenue Estimates
Synergy CHC Corp. Reports First Quarter 2026 Financial Results
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN)
New to The Street, a long-running sponsored television business brand, is broadcasting Show #752 on Bloomberg Television, featuring executive interviews and corporate updates from multiple companies. The episode includes Graphene Manufacturing Group, T-REX Acquisition Corp, KITON, and Roadzen, covering topics from advanced battery materials to AI-driven insurance technology. Sponsored commercials will also be shown from Synergy CHC Corp, YY Group Holding Limited, DataVault AI, Medicus Pharma Ltd, and IGC Pharma.
Synergy CHC Corp. (NASDAQ:SNYR) Short Interest Up 3,525.7% in April
Synergy CHC Q4 Earnings Call Highlights
Synergy CHC Corp. (SNYR) Q4 2025 Earnings Call Transcript
Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
Kenvue (NYSE:KVUE) vs. Synergy CHC (NASDAQ:SNYR) Head-To-Head Comparison
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
Synergy CHC (NASDAQ:SNYR) versus Colgate-Palmolive (NYSE:CL) Critical Review
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
Short Interest in Synergy CHC Corp. (NASDAQ:SNYR) Expands By 229.8%
Synergy CHC (NASDAQ:SNYR) and Colgate-Palmolive (NYSE:CL) Critical Contrast